Reporter Jan 11 2019 Archive
-
January 10, 2019
Duff’s traumatic brain injury research honored by NIDILRR
In support of her research to understand and improve long-term outcomes of individuals with traumatic brain injury, Melissa Duff, PhD, associate professor of Hearing and Speech Sciences, was recently named a 2018 Distinguished Switzer Research Fellow by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR). -
January 10, 2019
Anesthesiology project set to expand in Africa
Following the success of its ImPACT-Kenya (Improving Perioperative Anesthesia Care and Training) project, the Department of Anesthesiology has received another grant to expand into neighboring Ethiopia. -
January 10, 2019
Bile acids mediate metabolic benefits of weight-loss surgery
A team of Vanderbilt investigators has pinpointed the role of bile acids and a specific signaling pathway in the positive metabolic effects of weight-loss surgery. -
January 10, 2019
Seacrest surprise
Radio and television host and producer Ryan Seacrest recently made a surprise visit to Seacrest Studio at Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
January 7, 2019
Event to celebrate VUMC employees set for March 7-8
Vanderbilt University Medical Center is hosting a special employee appreciation event — Celebrate the Difference WE Make Every Day! — to applaud recent successes and acknowledge the many contributions of the Medical Center’s employees during three sessions on March 7-8. -
January 7, 2019
UT Southwestern’s Hobbs to discuss genetics of fatty liver disease
Helen Hobbs, MD, internationally renowned for her work defining the genetic determinants of plasma lipid levels and cardiovascular risk, will kick off the 2019 Flexner Discovery Lecture series Thursday, Jan. 10. -
January 7, 2019
GE Healthcare, Vanderbilt University Medical Center partner for safer, more precise immunotherapy cancer treatment
GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies.